Diabetic polyneuropathy not up with impaired glycemia

Diabetic polyneuropathy not up with impaired glycemia

(HealthDay) -- Although significantly increased in subjects with new diabetes, the rates of typical diabetic polyneuropathy (DPN), retinopathy, and nephropathy are not significantly different between subjects with and without impaired glycemia (IG), according to research published in the March issue of Diabetes Care.

Peter J. Dyck, M.D., of the Mayo Clinic in Rochester, Minn., and colleagues conducted a prospective, population-based survey of 150 subjects without IG, 174 with IG, and 218 with new diabetes to determine whether DPN, retinopathy, or nephropathy are more prevalent in subjects with IG than in healthy subjects.

The researchers found that the frequency of retinopathy and nephropathy was not significantly different between patients with and without IG, but was greater in those with new diabetes. The frequency of narrowly defined DPN was 2, 1.7, and 7.8 percent in non-IG, IG, and new diabetes subjects, respectively. Using a broader definition, the frequency of DPN was 12.7, 12.6, and 17.4 percent in non-IG, IG, and new diabetes subjects, respectively.

"Prevalence of typical DPN, , and nephropathy was significantly increased only in subjects with new diabetes," the authors write. "For atypical DPN, such an increase was not observed even in subjects with new diabetes. In , explanations other than IG should be sought for patients with atypical DPN (chronic idiopathic axonal polyneuropathy) who have IG."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Prediabetes may not explain diabetic polyneuropathies

Feb 22, 2012

In a reversal of two decades of medical reports, a Mayo Clinic study finds the frequency of nerve damage called diabetic polyneuropathy is similar in prediabetic patients and healthy people. Physicians should seek explanations ...

Ig Nobel 2006 Prize in mathematics

Oct 06, 2006

The 2006 Ig Nobel Prize in mathematics was awarded to Dr Piers Barnes and Ms Nic Svenson of CSIRO for figuring out how many photographs to take of a group of people to be confident of getting at least one where ...

Bottomless bowls are an Ig Nobel winner

Oct 12, 2007

Last week, he was featured in Time magazine and USA Today. This week, he's been accorded yet another accolade: a 2007 Ig Nobel Award. All three recognize Cornell's indefatigable Brian Wansink for his quirky ...

Let's stretch... Scientists study myomesin protein

Feb 14, 2012

The proteins actin, myosin and titin are big players in the business of muscle contraction. Scientists at the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, have now examined another muscle protein – ...

IG: Improvements in VA endoscopic equipment use

Sep 18, 2009

(AP) -- Inspections show that Veterans Department medical facilities have made significant progress on fixing endoscopic procedure problems that potentially exposed thousands to HIV and other infections.

Recommended for you

Blood glucose levels set for achieving HbA1c targets

Apr 11, 2014

(HealthDay)—The average self-monitored blood glucose (SMBG) concentrations needed at premeal, postmeal, and bedtime have been established to achieve a range of hemoglobin A1c (HbA1c) targets, according ...

Women with diabetes less likely to have a mammogram

Apr 11, 2014

Women with diabetes are 14 per cent less likely to be screened for breast cancer compared to women without diabetes, according to a study by researchers at the Institute for Clinical Evaluative Sciences (ICES) and Women's ...

Nonalcoholic fatty liver disease linked to CKD in T1DM

Apr 09, 2014

(HealthDay)—For patients with type 1 diabetes, nonalcoholic fatty liver disease (NAFLD) is independently associated with the risk of incident chronic kidney disease (CKD), according to a study published ...

Common diabetes treatment could extend hypoglycaemia

Apr 08, 2014

(Medical Xpress)—Researchers at the University of Adelaide have discovered that a common treatment for people with type 2 diabetes could cause longer-than-normal periods of the low blood sugar reaction hypoglycaemia, which ...

User comments